Skip to content
Search

Latest Stories

Forth Valley community pharmacy network pilot to support children with life-shortening conditions

Children’s Hospice Association Scotland (CHAS) and NHS Forth Valley are piloting an initiative involving pharmacists in a lead role to support babies, children and young people with life-shortening conditions, and their families.

From January to December this year, the network of 14 community pharmacies in Forth Valley will provide timely access to specialist medicines and paediatric palliative care advice in their local community for children diagnosed with life-shortening conditions.


The pilot will be regularly evaluated, helping to shape further development of community pharmacy-led services that are responsive to the needs of these children and their families.

Rose-Marie Parr, Chief Pharmaceutical Officer at the Scottish Government, said: “This is a great example of person-centred care which we know from evidence can have a positive impact on health outcomes. Through this pilot, pharmacists will be trained in the delivery of pharmaceutical paediatric palliative care and can pro-actively support parents to safely manage their children’s changing medication requirements.

“This is tailored to the individual needs of the parent and child and addresses any emerging health literacy issues head-on”.

All 14 community pharmacies participating in the pilot are part of the existing adult palliative care network, and the new service aims to capitalise on the clinical expertise of community pharmacists.

Anne Wilson, Specialist Palliative Care Pharmacist at NHS Forth Valley, said: "Children should have timely access to palliative care medicine and the 14 community pharmacists who are participating in the network are spread geographically across Forth Valley. They will hold key medication for palliative paediatric patients and help with any questions parents might have. The impact a community pharmacist can have on these patients in Forth Valley is extremely significant”.

A 2018 report has identified 857 children with a life-shortening condition requiring palliative care in Forth Valley alone. Only 36 per cent of those children are having a stay within hospital or CHAS services.

As the only Scotland-based charity providing hospice services for babies, CHAS aims to spread this across the country and explore how community and primary care-based pharmacists can provide a direct patient-facing medicines review and symptom control service for children with life-shortening conditions.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less